Opening book details…
About this Medicine article
A phase 3 study comparing tenofovir alafenamide (TAF) to tenofovir disoproxil fumarate (TDF) in patients with HBeAg-positive, chronic hepatitis B (CHB): efficacy and safety results at week 96 by Agarwal, K.; Fung, S.; Seto, W.K.; Lim, Y.S.; Gane, E.; Janssen, H.L.; Sharma, M.; Chuang, W.L.; Bae, H.; Yoon, K.T.; Flaherty, J.F.; Lau, A.; Gaggar, A.; Suri, V.; Cathcart, A.; Lin, L.; Subramanian, G.M.; Shalimar, ; Furusyo, N.; Buti, M.; Chan, H.L. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Agarwal, K.; Fung, S.; Seto, W.K.; Lim, Y.S.; Gane, E.; Janssen, H.L.; Sharma, M.; Chuang, W.L.; Bae, H.; Yoon, K.T.; Flaherty, J.F.; Lau, A.; Gaggar, A.; Suri, V.; Cathcart, A.; Lin, L.; Subramanian, G.M.; Shalimar, ; Furusyo, N.; Buti, M.; Chan, H.L.
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV; Wiley (ISSN 0168-8278)
- Published
- 2017
- Language
- EN
- Field
- Medicine (Health Sciences)